Orlando, FL -- (SBWIRE) -- 09/09/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On American International Group Inc(NYSE:AIG), Alpha Natural Resources, Inc. (NYSE:ANR).
American International Group Inc(NYSE:AIG) shares fell 1.01% to $48.18. The company on August 27 announced the appointment of Damian Coory to the newly created role of Vice President for Corporate Marketing and Communications for Asia Pacific. Mr. Coory will report to Christina Pretto, Senior Vice President, Corporate Communications, and will also have a matrix reporting line to Jose Hernandez, Chief Executive Officer, Asia Pacific. He will be based in Hong Kong, the new base of the regional communications operation.
Additionally, the company on August 15 announced that it is now offering globally up to $100 million in limits for Side A Directors and Officers (D&O) liability insurance. This new capacity from AIG, combined with the insurer's financial strength and claims handling experience, can facilitate the efficient resolution of severe and complex litigation. Companies can now meet their Side A needs by significantly reducing the number of insurance carriers and policy layers necessary for adequate coverage, creating a more efficient D&O insurance structure.
Are investors worried about the recent updates with AIG? Find out with a free trend analysis HERE
Alpha Natural Resources, Inc. (NYSE:ANR) shares decreased 1.10% to $6.30. The company on August 28 announced topline results from the ongoing phase 2 of SGI-110 in patients with AML and MDS. The Phase 2 study is a randomized study of SGI-110 given either as 60 or 90 mg/m2 daily for 5 days in a 28-day course. As of end of June data cutoff, 67 AML patients had a minimum follow up of 3 months (50 patients representing the complete cohort of relapsed/refractory AML, and 17 patients in the treatment-naive elderly AML not suitable for induction chemotherapy cohort).
Additionally, the company on August 2 reported a loss of 59 cents per share for the second quarter of 2013, narrower than the Consensus Estimate of a loss of 60 cents. The company's GAAP loss was 84 cents per share versus earnings of $10.14 per share a year ago. The company’s total revenues was $1,335.1 million in the second quarter were higher than the Consensus Estimate by $91.1 million.
Is ANR going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)